Financials Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:02 2025-12-05 pm EST			5-day change	1st Jan Change
225.85 ^USD	+0.41%		-1.81%	+14.93%

Dec. 02	Amneal Pharmaceuticals, Inc. Receives U.S. Fda Approval for Albuterol Sulfate Inhalation Aerosol	CI
Dec. 02	Iqvia announces strategic collaboration with AWS, naming AWS as preferred agentic cloud provider to power next-generation AI platform	RE

Projected Income Statement: Iqvia Holdings Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net sales ¹	11,359	13,874	14,410	14,984	15,405	16,188	17,060	18,022
Change	-	22.14%	3.86%	3.98%	2.81%	5.09%	5.38%	5.64%
EBITDA ¹	2,384	3,022	3,346	3,569	3,684	3,753	3,973	4,231
Change	-	26.76%	10.72%	6.66%	3.22%	1.88%	5.84%	6.5%
EBIT ¹	2,030	2,591	2,779	3,050	3,100	2,394	2,659	2,929
Change	-	27.64%	7.26%	9.75%	1.64%	-22.77%	11.08%	10.15%
Interest Paid ¹	-410	-369	-403	-636	-623	-694.1	-715	-721.9
Earnings before Tax (EBT) ¹	373	1,128	1,363	1,459	1,669	1,519	1,751	2,015
Change	-	202.41%	20.83%	7.04%	14.39%	-8.98%	15.27%	15.06%
Net income ¹	279	966	1,091	1,358	1,373	1,235	1,451	1,672
Change	-	246.24%	12.94%	24.47%	1.1%	-10.06%	17.54%	15.18%
Announcement Date	2/10/21	2/15/22	2/10/23	2/14/24	2/6/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: December	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3
Net sales ¹	3,298	3,409	3,438	3,391	3,636	3,568	3,541	3,562	3,739	3,652	3,728	3,736	3,868	3,737	3,814	3,896	3,958	3,829	4,017	4,100	4,241	4,077	4,230	4,291	4,443	4,298	4,436	4,497
Change	-	3.37%	0.85%	-1.37%	7.23%	-1.87%	-0.76%	0.59%	4.97%	-2.33%	2.08%	0.21%	3.53%	-3.39%	2.06%	2.15%	1.59%	-3.26%	4.91%	2.07%	3.44%	-3.86%	3.73%	1.44%	3.55%	-3.26%	3.21%	1.36%
EBITDA ¹	735	744	722	728	828	812	800	814	920	851	864	888	966	862	887	939	996	883	910	949	1,041	935.4	954.6	996.2	1,095	979.8	995.7	1,028
Change	-	1.22%	-2.96%	0.83%	13.74%	-1.93%	-1.48%	1.75%	13.02%	-7.5%	1.53%	2.78%	8.78%	-10.77%	2.9%	5.86%	6.07%	-11.35%	3.06%	4.29%	9.67%	-10.13%	2.05%	4.36%	9.94%	-10.53%	1.62%	3.29%
EBIT ¹	633	646	618	623	704	691	682	694	712	721	737	747	821	717	750	788	845	496	506	553	702.1	566	581.7	613	708	650	684	683
Change	-	2.05%	-4.33%	0.81%	13%	-1.85%	-1.3%	1.76%	2.59%	1.26%	2.22%	1.36%	9.91%	-12.67%	4.6%	5.07%	7.23%	-41.3%	2.02%	9.29%	26.97%	-19.39%	2.77%	5.39%	15.5%	-8.19%	5.23%	-0.15%
Charge d'intérêts ¹	-98	-98	-93	-90	-88	-85	-92	-104	-122	-135	-165	-167	-169	-155	-151	-157	-160	-154	-172	-176	-180.8	-177	-177.3	-177.3	-177.3	-	-	-
Earnings before Tax (EBT) ¹	194	257	222	273	376	400	328	360	275	362	375	349	373	340	436	349	544	323	323	408	485.2	379.2	395.8	430.5	520.2	428	461.5	484
Change	-	32.47%	-13.62%	22.97%	37.73%	6.38%	-18%	9.76%	-23.61%	31.64%	3.59%	-6.93%	6.88%	-8.85%	28.24%	-19.95%	55.87%	-40.62%	0%	26.32%	18.93%	-21.84%	4.35%	8.78%	20.85%	-17.73%	7.83%	4.88%
Net income ¹	119	212	175	261	318	325	256	283	227	289	297	303	469	288	363	285	437	249	266	331	399.6	305	321.5	349.5	424	341	374.5	393
Change	-	78.15%	-17.45%	49.14%	21.84%	2.2%	-21.23%	10.55%	-19.79%	27.31%	2.77%	2.02%	54.79%	-38.59%	26.04%	-21.49%	53.33%	-43.02%	6.83%	24.44%	20.72%	-23.67%	5.41%	8.71%	21.32%	-19.58%	9.82%	4.94%
Announcement Date	2/10/21	4/22/21	7/27/21	10/21/21	2/15/22	4/27/22	7/21/22	10/26/22	2/10/23	4/27/23	8/1/23	11/1/23	2/14/24	5/2/24	7/22/24	10/31/24	2/6/25	5/6/25	7/22/25	10/28/25	-	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: Iqvia Holdings Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Net Debt ¹	10,631	10,759	11,531	12,297	12,281	13,365	12,678	11,461
Change	-	1.2%	7.18%	6.64%	-0.13%	8.83%	-5.14%	-9.6%
Announcement Date	2/10/21	2/15/22	2/10/23	2/14/24	2/6/25	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: Iqvia Holdings Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	616	640	674	649	602	594.9	611.6	644.3
Change	-	3.9%	5.31%	-3.71%	-7.24%	-1.19%	2.81%	5.35%
Free Cash Flow (FCF) ¹	1,343	2,302	1,586	1,500	2,114	1,962	2,150	2,366
Change	-	71.41%	-31.1%	-5.42%	40.93%	-7.17%	9.54%	10.08%
Announcement Date	2/10/21	2/15/22	2/10/23	2/14/24	2/6/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: Iqvia Holdings Inc.

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Profitability
EBITDA Margin (%)	20.99%	21.78%	23.22%	23.82%	23.91%	23.19%	23.29%	23.47%
EBIT Margin (%)	17.87%	18.68%	19.29%	20.36%	20.12%	14.79%	15.59%	16.25%
EBT Margin (%)	3.28%	8.13%	9.46%	9.74%	10.83%	9.38%	10.27%	11.18%
Net margin (%)	2.46%	6.96%	7.57%	9.06%	8.91%	7.63%	8.51%	9.28%
FCF margin (%)	11.82%	16.59%	11.01%	10.01%	13.72%	12.12%	12.6%	13.13%
FCF / Net Income (%)	481.36%	238.3%	145.37%	110.46%	153.97%	158.92%	148.11%	141.56%
Profitability
ROA	1.17%	7.15%	7.74%	5.22%	5.12%	5.65%	6.1%	6.8%
ROE	20.86%	29.23%	32.81%	32.01%	33.53%	32.66%	31.67%	29.94%
Financial Health
Leverage (Debt/EBITDA)	4.46x	3.56x	3.45x	3.45x	3.33x	3.56x	3.19x	2.71x
Debt / Free cash flow	7.92x	4.67x	7.27x	8.2x	5.81x	6.81x	5.9x	4.84x
Capital Intensity
CAPEX / Current Assets (%)	5.42%	4.61%	4.68%	4.33%	3.91%	3.67%	3.58%	3.58%
CAPEX / EBITDA (%)	25.84%	21.18%	20.14%	18.18%	16.34%	15.85%	15.4%	15.23%
CAPEX / FCF (%)	45.87%	27.8%	42.5%	43.27%	28.48%	30.31%	28.45%	27.23%
Items per share
Cash flow per share ¹	10.05	15.09	11.86	11.54	14.81	15.12	17.49	20.1
Change	-	50.18%	-21.41%	-2.67%	28.33%	2.11%	15.67%	14.93%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	31.39	30.98	31.04	32.81	33.08	37.29	43.49	51.38
Change	-	-1.29%	0.19%	5.68%	0.83%	12.71%	16.65%	18.14%
EPS ¹	1.43	4.95	5.72	7.29	7.49	7.103	8.52	9.935
Change	-	246.15%	15.56%	27.45%	2.74%	-5.16%	19.95%	16.6%
Nbr of stocks (in thousands)	191,726	191,040	185,740	182,500	181,500	170,300	170,300	170,300
Announcement Date	2/10/21	2/15/22	2/10/23	2/14/24	2/6/25	-	-	-